Rheumatology Association of Iowa 5th Annual Meeting
If you have questions, please contact Lorene Harder at firstname.lastname@example.org or 847-264-5912.
Effective management in ANCA-associated vasculitis (AAV), specifically Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) include not only the use of evidence-based treatments but also rigorous application of monitoring and preventive strategies to reduce the risk of infection and medication-specific toxicities. Rheumatologists need to be aware of these strategies to provide their patients with the best outcomes.
For the two main forms of Large-vessel vasculitis (LVV), Giant Cell Arteritis (GCA) and Takayasu Arteritis (TAK), non-medical management should be considered for disease that is threatening a critical organ or for significant symptoms impacting quality of life.
Today’s challenging health care environment is affecting the way physicians manage their practices, interfering with access to care and forcing them to make difficult decisions. Physicians seek to continue to provide quality care while contending with reduced Medicare reimbursement rates, medical claims, process errors and inefficiency, and legislative and regulatory changes. Rheumatologists need to be aware of emerging trends in practice management, payer reform, and administrative simplification of impact to the success of their practices and quality of patient care.
- Recognize federal efforts to improve value in healthcare delivery and payment through programs established under the Medicare Access and CHIP Reauthorization Act (MACRA)
- Distinguish and contrast pathways for Rheumatologists to be reimbursed under the Quality Payment Program (i.e., the Merit-Based Incentive Payment System (MIPS) and Alternative Payment Models (APMs).
- Evaluate the potential impact of MACRA on Rheumatology practices and estimate the significance of engagement in current and future value-driven delivery and payment models.
- Identify opportunities for state and national advocacy, legislative action and our need for representation at the state national level.
- Identify the clinical features of ANCA-associated vasculitis.
- Describe the approach to diagnosis for ANCA-associated vasculitis.
- List the treatment options for ANCA-associated vasculitis.
- Describe the diseases that can be associated with large vessel vasculitis.
- Identify the clinical features associated with giant cell arteritis and Takayasu arteritis.
- Discuss the treatment approaches to giant cell arteritis and Takayasu arteritis.
All sessions will be located in the Amphitheater unless otherwise noted. Speakers and times are subject to change.
|Friday, March 1|
Welcome and Opening Remarks
Michael S. Brooks, MD, FACP, FACR
How Current Iowa Laws Passed Affect Those Practicing Rheumatology Today
|Saturday, March 2|
Welcome and Announcements
ANCA-Associated Vasculitis: Clinical Aspects and Management
Carol A. Langford, MD, MHS, FACP
Large Vessel Vasculitis in 2019
Carol A. Langford, MD, MHS, FACP
|11:45 am||RAI Annual Business Meeting and Lunch|
Relevant to the content of this educational activity, the following individuals have no conflict of interests with commercial interests to disclose.
- Michael S. Brooks, MD, FACP, FACR, Activity Director and Planning Committee Member
- Lorene Harder, Planning Committee Member
- Candace Milbourn, Planning Committee Member
- David B. Staub, MD, Planning Committee Member
Relevant to the content of this educational activity, the following individuals a conflict of interest with commercial interests to disclose.
The Hotel Kirkwood Center is offering RAI attendees a special conference rate of $134.00, plus applicable state and local taxes. This discounted group rate applies until the reservation deadline of February 7, 2019, or until all so-designated rooms are booked, whichever occurs first. RAI encourages you to make your reservations early, as after this date reservations will be accepted based on hotel availability and/or higher rates may apply.
BE SURE TO MENTION THE RAI 5TH ANNUAL MEETING TO RECEIVE THE DISCOUNTED RATE.
Continuing Education Credit
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 5.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Rheumatology Association of Iowa. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 5.0 continuing education contact hour(s). No partial credit awarded.
- Other: This live activity is designated for 5.0 AMA PRA Category 1 Credit(s)TM.
No commercial interest company provided financial support for this continuing education activity.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 4.50 AOA Category 2A
- 4.50 AMA PRA Category 1 Credits™
- 4.50 IBON
- 4.50 CE Contact Hours